🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for NEC

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC NCT07416695Phase 12 sites📍 Beijing📍 Shanghai Shanghai Henlius Biotech · Tests: HLX3901 A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma NCT06157827Phase 1, Phase 225 sites📍 Hefei📍 Hefei📍 Beijing Nanjing Leads Biolabs Co.,Ltd · Tests: LBL-024 for Injection, Etoposide Injection, Carboplatin Injection, Atezolizumab injection, Cisplatin injection Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors NCT07278479Phase 1, Phase 28 sites📍 Tampa📍 Atlanta📍 Chicago Molecular Partners AG · Tests: [212Pb]Pb-MP0712, [203Pb]Pb-MP0712 Administration of Extracellular Vesicles From Donor Human Milk in Preterm Infants NCT07402083n/a1 site📍 Valencia Instituto de Investigacion Sanitaria La Fe · Tests: Donor human milk extracellular vesicles (DHM-EVs) Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites📍 Iowa City📍 Boston📍 Royal Oak Novartis Pharmaceuticals · Tests: 225Ac-ETN029, 111In-ETN029 Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants NCT07045844NA24 sites📍 Guilin📍 Yulin📍 Zhengzhou The Children's Hospital of Zhejiang University School of Me… · Tests: Pasteurized Donor Milk for Insufficient Breastfeeding, Preterm Formula for Insufficient Breastfeeding, Routine fortific… A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity NCT06406465Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Belinostat, Cisplatin, Etoposide ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma NCT07038096Phase 1, Phase 21 site📍 Guanzhou Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Tests: ZG006, ZG005 WithHolding Enteral Feeds Around Blood Transfusion (International) NCT05213806NA40 sites📍 Halifax📍 Norwich📍 Hillingdon IWK Health Centre · Tests: Withholding feeds around transfusion, Continued feeds around transfusion Study of Normal Intestinal Development and Disease in Premature and Term Neonates NCT06681129n/a1 site📍 Boston Boston Children's Hospital 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: [18F]FAPI-74, [18F]FDG The Correlation Between Red Cell Transfusion and Complications of Prematurity NCT07123948n/a1 site📍 Rijeka Clinical Hospital Center Rijeka · Tests: Wechsler Intelligence Test, performed by educated psychologists Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients NCT06893783Phase 24 sites📍 Seoul📍 Seoul📍 Seoul Inkeun Park · Tests: Tarlatamab Delayed Versus Immediate Cord Clamping in Preterm Birth NCT07699666NA1 site📍 Tunis Faculty of Medicine of Tunis · Tests: Delayed Umbilical Cord Clamping, Immediate Umbilical Cord Clamping A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) NCT07488923Phase 17 sites📍 St Louis📍 Hackensack📍 New York Moonlight Bio, Inc · Tests: ML261 Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE) NCT05165407Phase 22 sites📍 Beijing📍 Beijing Peking University · Tests: Sintilimab, IBI310, Surufatinib A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer NCT07174583Phase 1, Phase 213 sites📍 Denver📍 Orlando📍 Fort Wayne IDEAYA Biosciences · Tests: IDE849, durvalumab, IDE161, Carboplatin Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC). NCT07192393n/a7 sites📍 Norwich📍 Coventry📍 Liverpool Imperial College London A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma NCT04923126Phase 1, Phase 21 site📍 Memphis St. Jude Children's Research Hospital · Tests: Mirdametinib Qualitative Study of Surgeons With Prospective Patient Follow-up NCT06032676n/a1 site📍 Southampton University Hospital Southampton NHS Foundation Trust Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC NCT05636397NA1 site📍 Toronto The Hospital for Sick Children · Tests: L-Citrulline Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study NCT06672913NA1 site📍 Ankara Baskent University Ankara Hospital · Tests: skin to skin contact care A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) NCT05652686Phase 1, Phase 215 sites📍 Duarte📍 Los Angeles📍 Denver Phanes Therapeutics · Tests: Peluntamig (PT217), Carboplatin + Etoposide, Paclitaxel., Atezolizumab, Lurbinectedin Gut Permeability and Microbiome in Preterm Infants NCT07667049Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: measurement of intestinal permeability Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma NCT07518602Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Chidamide, Sintilimab, Bevacizumab Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality NCT07273643n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Venous Cord blood sample, Arterial cord blood sample The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease NCT06092463n/a2 sites📍 Copenhagen📍 Odense Copenhagen University Hospital, Rigshospitalet SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) NCT06889493Phase 11 site📍 Miami Peter Hosein, MD · Tests: Seneca Valley Virus-001 (SVV-001), Nivolumab, Ipilimumab PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants NCT05272579EARLY Phase 11 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Fecal Filtrate Transfer, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy